Table 2.
Stage, level of differentiation, treatment and outcome for 49 individuals with SLCT.
| Stage | Differentiation | Adjuvant Chemo | Surgery Only | NED | Metachronous | Relapse | DOD |
|---|---|---|---|---|---|---|---|
|
| |||||||
| IA | Well (n=2) | 0 | 2 | 2 | 0 | 0 | 0 |
| [T1aN0M0] (n=27) | Intermediate (n=20) | 3 | 17 | 20 | 2 | 0 | 0 |
| Poor (n=4) | 3 | 1 | 4 | 1 | 0 | 0 | |
| Unknown (n=1) | 1 | 0 | 1 | 0 | 0 | 0 | |
|
| |||||||
| IC [T1cN0M0] (n=6) | Intermediate (n=1) | 0 | 1 | 0 | 0 | 1 | 1 |
| Poor (n=5) | 2 | 3 | 2 | 0 | 3 | 1 | |
|
| |||||||
| IC1 [T1C1N0M0] (n=6) | Intermediate (n=2) | 2 | 0 | 2 | 0 | 0 | 0 |
| Poor (n=3) | 1 | 2 | 2 | 0 | 1 | 1 | |
| Unknown (n=1) | 1 | 0 | 1 | 0 | 0 | 0 | |
|
| |||||||
| >IC [T1cN0M0] (n=4) | Intermediate (n=2) | 2 | 0 | 2 | 0 | 0 | 0 |
| Poor (n=2) | 2 | 0 | 0 | 0 | 1 | 0 | |
|
| |||||||
| Unknown (n=6) | Well (n=1) | 0 | 1 | 1 | 0 | 0 | 0 |
| Intermediate (n=1) | 0 | 1 | 1 | 0 | 0 | 0 | |
| Unknown (n=4) | 1 | 3 | 2 | 0 | 2 | 1 | |
|
| |||||||
| All stages (n=49) | Well (n=3) | 0 | 3 | 3 | 0 | 0 | 0 |
| Intermediate (n=26) | 7 | 19 | 25 | 2 | 1 | 1 | |
| Poor (n=14) | 8 | 6 | 8 | 1 | 5 | 2 | |
| Unknown (n=6) | 3 | 3 | 4 | 0 | 2 | 1 | |
FIGO 1a: limited to one ovary, capsule intact, negative washings; 1c1: surgical spill. SLCT= Sertoli-Leydig cell tumor, NED= no evidence of disease, DOD= died of disease, Chemo= chemotherapy, NOS= not otherwise specified